Medical Device | December 30, 2021
Siemens Healthineers receive EUA for Covid-19 antigen self-test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
It will be marketed under the brand name Molunamax
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use
DCGI approved the drug based on the review of clinical data
The drug will be marketed under the brand name Molnaflu
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
Subscribe To Our Newsletter & Stay Updated
